Coldstream Laboratories announces manager of technology transfer

Sholto Maclean takes newly created role at Kentucky firm

Coldstream Laboratories, a US provider of drug product research and manufacturing services specialising in high potency and cytotoxic parenteral products, based in Lexington, Kentucky, has named Sholto Maclean as manager of technology transfer.

In this newly created position, Maclean will work with Coldstream's pharmaceutical development team to scale up processes for sterile liquid and lyophilised drug products for manufacturing in the company's sterile facility.

Maclean has more than 20 years of experience in parenteral processing, sterile product development, lyophilisation development and aseptic manufacturing. Most recently, he was a lyophilisation/technology transfer consultant for a major pharmaceutical company. Previous roles include positions at GlaxoSmithKline and DSM Pharmaceuticals.

Coldstream Laboratories operates the only sterile pharmaceutical manufacturing facility in Kentucky.

You may also like

Manufacturing

Piramal acquires Coldstream Laboratories for US$30.65m

Kentucky based CDMO specialises in sterile liquid and freeze-dried parenterals and injectables
Manufacturing

OMRON introduces new high-payload collaborative robots and TMflow software upgrade

OMRON unveils advanced collaborative robots and upgraded TMflow software to boost manufacturing flexibility and productivity
Manufacturing

Sharp Services invests more than €20m to expand injectables packaging capacity at its European facilities

Expansion includes significant cold chain warehouse capacity to support injectable formats
Ingredients

SÜDPACK Medica showcases recyclable blister and medical packaging innovations at PharmaPack 2026

From recyclable PP blisters to cleanroom-manufactured pouch solutions, SÜDPACK Medica highlights sustainability and performance in pharma packaging
Manufacturing

Key drivers behind the rise of microsphere drug delivery systems

Microspheres shift drug delivery from broad distribution to precise targeting. These systems improve therapeutic consistency, lower systemic exposure, and adapt to complex treatment regimens. Their growth reflects progress in polymer science, pharmacokinetics, and the push for more individualised care in clinical settings. Let’s explore some of the key drivers behind the rise of microsphere drug delivery systems and look ahead to predict future growth trends
Manufacturing

Inside the shift toward greener, faster, Smarter drug manufacturing

Dave Henderson, Ph.D, MBA, Head of R&D Labs at Asymchem explores the pharmaceutical manufacturing landscape and the challenges CDMOs must address to remain competitive in this shifting market
Manufacturing

Onyx Scientific boosts solid form and particle engineering capabilities

Marking its 25th anniversary, Onyx Scientific has invested in new crystallisation, particle imaging and processing technologies to accelerate development of complex molecules across early and late stages
Subscribe now